Evidence map›Paper›PMID 42179273›Full record

Trial reportJournal of the American Heart Association2026

Association of 24-Hour Computed Tomography Infarct Density on Functional Outcomes in Stroke: Secondary Analysis From the AcT Trial.

Umberto Pensato, Jianhai Zhang, Kazbek Barakhanov, Koji Tanaka, Fouzi Bala, Chitapa Kaveeta, Mohammed Almekhlafi, Dar Dowlatshahi, Thalia S Field, Aleksander Tkach and 11 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Umberto PensatoIRCCS Humanitas Research Hospital Milan Italy.ORCID 0000-0002-4042-4735
Jianhai ZhangDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0002-0330-6908
Kazbek BarakhanovDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0001-8152-1382
Koji TanakaDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0001-6501-4057
Fouzi BalaDiagnostic and Interventional Neuroradiology Department University Hospital of Tours France.ORCID 0000-0001-6748-2081
Chitapa KaveetaDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0001-8316-6820
Mohammed AlmekhlafiDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0001-9550-8197
Dar DowlatshahiDepartment of Medicine, Division of Neurology University of Ottawa Ottawa Canada.ORCID 0000-0003-1379-3612
Thalia S FieldVancouver Stroke Program, Division of Neurology University of British Columbia Vancouver BC Canada.ORCID 0000-0002-1176-0633
Aleksander TkachInterior Health Kelowna BC Canada.ORCID 0009-0009-4063-4431
Rick SwartzDivision of Neurology, Department of Medicine, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre University of Toronto ON Canada.ORCID 0000-0001-6571-5531
Gary HunterUniversity of Saskatchewan Saskatoon SK Canada.ORCID 0000-0003-2033-8001
Jai J S ShankarDepartment of Radiology-Neuroradiology, Rady Faculty of Health Sciences University of Manitoba Winnipeg MB Canada.ORCID 0000-0002-3707-9723
Ayoola AdemolaDepartment of Community Health Sciences and O'Brien Institute for Public Health University of Calgary AB Canada.ORCID 0000-0002-8412-6246
Michel ShamyDepartment of Medicine, Division of Neurology University of Ottawa Ottawa Canada.ORCID 0000-0002-0085-6816
Sherry X HuDalhousie Department of Medicine Division of Neurology Halifax NS Canada.ORCID 0000-0001-6251-2405
Gordon GubitzDalhousie Department of Medicine Division of Neurology Halifax NS Canada.ORCID 0000-0001-7999-7728
Andrew M DemchukDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0002-4930-7789
Bijoy K MenonDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0002-3466-496X
Aravind GaneshDepartment of Clinical Neurosciences University of Calgary AB Canada.ORCID 0000-0001-5520-2070
Nishita SinghDepartment of Internal Medicine (Neurology Division), Rady Faculty of Health Sciences University of Manitoba Winnipeg MB Canada.ORCID 0000-0003-3647-0904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe final infarct volume has been historically considered the most critical radiological outcome in ischemic stroke. Yet, discrepancies between final infarct volume and functional outcomes occur frequently. We aim to evaluate whether 24-hour computed tomography (CT) infarct density modifies the relationship between 24-hour CT infarct volume and functional outcomes and is associated with outcomes in acute ischemic stroke.

methodsData are from the AcT (Alteplase Versus Tenecteplase in AIS [Acute Ischemic Stroke] Within 4.5 Hours) trial. Patients with detected 24-hour CT infarct and no parenchymal hematoma were included. To capture within-lesion heterogeneity, "24-hour CT standardized infarct density" was calculated as mean Hounsfield Unit/SD for every patient. Primary outcome was the 90-day ordinal modified Rankin Scale score. We assessed effect modification using interaction terms and performed adjusted regression analyses.

resultsOf 1577 patients, 839 (53.2%) were included (median age 75 years [interquartile range, 64-84], 414 [9.3%] female). Median infarct volume was 7.5 mL (interquartile range, 1.6-28.0), and median standardized infarct density was 4.8 standardized-Hounsfield Units (interquartile range, 4.0-5.8). Standardized infarct density significantly modified the effect of infarct volume on modified Rankin Scale score (

conclusionsCT infarct density modifies the effect of infarct volume on outcomes and is independently associated with better outcomes. These findings suggest that 24-hour CT infarct volume and density may provide complementary information on the infarct burden.

Indexed as

Fibrinolytic AgentsIschemic StrokeTenecteplaseThrombolytic TherapyTissue Plasminogen ActivatorTomography, X-Ray ComputedAgedAged, 80 and overFemaleFunctional StatusHumansMaleMiddle AgedRecovery of FunctionTime FactorsTreatment OutcomeFibrinolytic AgentsTenecteplaseTissue Plasminogen Activatorcerebral edemacerebral infarct growthhypodensityincomplete infarctioninfarct severityinfarct volumeischemic core

Identifiers

PMID42179273
PMCPMC13315149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.